Ko Tanaka

489 total citations
9 papers, 373 citations indexed

About

Ko Tanaka is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Ko Tanaka has authored 9 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Ko Tanaka's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Virus-based gene therapy research (4 papers). Ko Tanaka is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Virus-based gene therapy research (4 papers). Ko Tanaka collaborates with scholars based in Japan. Ko Tanaka's co-authors include Yuuki Takashima, Takanori Kanazawa, Hiroaki Okada, Tsunehiko Fukuda, Ken Sugawara, Hiroaki Okada, Takaya Ogawa, Yasuo Seta, Mariko Okamoto and Hiroyuki Mizuguchi and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Ko Tanaka

9 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ko Tanaka Japan 8 291 124 72 56 47 9 373
Kadi-Liis Veiman Estonia 9 348 1.2× 92 0.7× 24 0.3× 74 1.3× 63 1.3× 10 445
Ebbe Juel Bech Nielsen Denmark 7 456 1.6× 80 0.6× 134 1.9× 42 0.8× 57 1.2× 7 538
Emma McErlean United Kingdom 9 229 0.8× 139 1.1× 62 0.9× 107 1.9× 45 1.0× 14 429
Sys Zoffmann Glud Denmark 4 514 1.8× 107 0.9× 117 1.6× 64 1.1× 80 1.7× 6 632
Melika Kiani Iran 10 193 0.7× 197 1.6× 51 0.7× 99 1.8× 16 0.3× 12 397
Lynn De Backer Belgium 9 308 1.1× 112 0.9× 61 0.8× 119 2.1× 19 0.4× 11 489
Beatriz Santos-Carballal Germany 5 212 0.7× 86 0.7× 59 0.8× 42 0.8× 38 0.8× 7 327
Pedro M. D. Moreno Sweden 16 636 2.2× 72 0.6× 27 0.4× 35 0.6× 99 2.1× 32 718
Guangyu Rong China 9 227 0.8× 100 0.8× 23 0.3× 111 2.0× 24 0.5× 16 385

Countries citing papers authored by Ko Tanaka

Since Specialization
Citations

This map shows the geographic impact of Ko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Tanaka more than expected).

Fields of papers citing papers by Ko Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Tanaka. The network helps show where Ko Tanaka may publish in the future.

Co-authorship network of co-authors of Ko Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Ko Tanaka. A scholar is included among the top collaborators of Ko Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Tanaka. Ko Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Okamoto, Mariko, et al.. (2016). Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia. Veterinary Research Communications. 40(3-4). 131–139. 2 indexed citations
2.
Okada, Hiroaki, Takaya Ogawa, Ko Tanaka, Takanori Kanazawa, & Yuuki Takashima. (2014). Cytoplasm-Responsive Delivery Systems for siRNA Using Cell-Penetrating Peptide Nanomicelles. Journal of Drug Delivery Science and Technology. 24(1). 3–11. 7 indexed citations
3.
Tanaka, Ko, Takanori Kanazawa, Ken Sugawara, et al.. (2013). Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. International Journal of Pharmaceutics. 455(1-2). 40–47. 44 indexed citations
4.
Kanazawa, Takanori, et al.. (2012). Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG–PCL nanomicelles. European Journal of Pharmaceutics and Biopharmaceutics. 81(3). 470–477. 51 indexed citations
5.
Kanazawa, Takanori, et al.. (2011). Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration. Pharmaceutical Research. 28(9). 2130–2139. 123 indexed citations
6.
Tanaka, Ko, et al.. (2011). A cytoplasm-sensitive peptide vector cross-linked with dynein light chain association sequence (DLCAS) enhances gene expression. International Journal of Pharmaceutics. 419(1-2). 231–234. 11 indexed citations
7.
Tanaka, Ko, Takanori Kanazawa, Takaya Ogawa, et al.. (2011). A Novel, Bio-Reducible Gene Vector Containing Arginine and Histidine Enhances Gene Transfection and Expression of Plasmid DNA. Chemical and Pharmaceutical Bulletin. 59(2). 202–207. 24 indexed citations
8.
Tanaka, Ko, et al.. (2010). Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery. International Journal of Pharmaceutics. 396(1-2). 229–238. 57 indexed citations
9.
Tanaka, Ko, Takanori Kanazawa, Takaya Ogawa, et al.. (2010). Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing. International Journal of Pharmaceutics. 398(1-2). 219–224. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026